• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MDT PUERTO RICO OPERATIONS CO SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MDT PUERTO RICO OPERATIONS CO SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-20
Device Problems Electromagnetic Interference (1194); Volume Accuracy Problem (1675)
Patient Problems Fatigue (1849); Memory Loss/Impairment (1958); Muscle Spasm(s) (1966); Muscle Weakness (1967); Overdose (1988); Therapeutic Response, Decreased (2271); Complaint, Ill-Defined (2331); Decreased Respiratory Rate (2485); Sleep Dysfunction (2517)
Event Date 06/19/2018
Event Type  Injury  
Manufacturer Narrative
(b)(6).If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a foreign healthcare professional (hcp) via a manufacturer representative regarding a patient who was receiving baclofen 3,000.0 mcg/ml at 600.1 mcg/day via an implantable pump for an unknown indication for use.It was reported that on (b)(6) 2018, the patient had a magnetic resonance imaging (mri).It was reported that the patient became unwell and was showing symptoms of baclofen withdrawal.The patient came to outpatient and pump telemetry was read.The pump logs were provided and indicated that there was a motor stall that occurred on (b)(6) 2018 at 15:24, a "stopped pump period may exceed tube set" that occurred on (b)(6) 2018 at 15:24, and a motor stall recovery occurred on (b)(6) 2018 at 16:28.The logs also indicated that an active, audible alarm was silenced on (b)(6) 2018 at 16:24.No further complications were reported and/or anticipated.
 
Manufacturer Narrative
(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a foreign manufacturer representative.It was reported the pump had not been explanted.The patient elected not to use intrathecal baclofen and not to have another surgery, so the pump and the catheter system had been emptied, filled with sterile water and programmed at the minimal infusion (shelf mode).There was no recent record of the patient¿s body weight, but the patient did not weigh more than (b)(6).
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a foreign healthcare professional (hcp) via a manufacturer representative.It was reported the cause of the overdose symptoms was not determined, and the patient's age at the time of the event was not available.
 
Manufacturer Narrative
Updated (withdrawal no longer applies) b6 updated (patient code no longer applies).If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from a foreign healthcare professional (hcp) via a manufacturer representative.It was reported that the patient did not present with cessation of intrathecal baclofen therapy but had all the symptoms and signs of overinfusion of baclofen.The hcp clarified that the patient presented to the hcp with baclofen overdose symptoms on 2018 (b)(6), not baclofen withdrawal as the hcp previously mentioned (even though the patient mentioned increased spasms for 4 days before presenting with an inability to keep himself awake).The patient experienced symptoms of excessive drowsiness, awakening then lapsing into sleep again, low respiratory rate, lapses/impairment of recent memory (could not recall the events properly what went on in the preceding 24 hours), extremely floppy legs and trunk.On 2018 (b)(6), the pump was interrogated and put in shelf-mode at ¿18 mcg of baclofen dose since 2018 (b)(6) 1800 hours.¿ the patient still had flaccidity of both legs on the morning 2018 (b)(6), and the hcp was keeping the shelf-mode dosage going with further review to occur on 2018 (b)(6).The hcp disagreed with any conclusions of ¿probable blockage of the tubing and replacing the pump¿.The hcp initially could not see the clinical indication of subjecting the patient for surgery on the available clinical findings at present (an overinfusion clinical symptom complex).The hcp would be continuing to keep a close watch, and the patient had been advised to contact the center.It was later clarified on 2018 (b)(6) that the hcp now planned to replace the pump even though the patient still did not have any significant spasms.The pump reservoir was aspirated on the morning of 2018 (b)(6).Telemetry showed 1.9 ml, but the actual reflux was 3.9 ml.The hcp inquired if it was possible the pump delivered a higher dose by restarting itself on 2018(b)(6) or 2018(b)(6) when the patient was struggling to keep himself awake.The pump would be returned to the device manufacturer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MDT PUERTO RICO OPERATIONS CO
rd 31 km 24 hm 4
juncos PR 00777
Manufacturer (Section G)
MDT PUERTO RICO OPERATIONS CO
rd 31 km 24 hm 4
juncos PR 00777
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key7650819
MDR Text Key112741111
Report Number3004209178-2018-14664
Device Sequence Number1
Product Code LKK
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup
Report Date 08/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/14/2015
Device Model Number8637-20
Device Catalogue Number8637-20
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/27/2018
Initial Date FDA Received06/29/2018
Supplement Dates Manufacturer Received06/28/2018
08/10/2018
08/22/2018
Supplement Dates FDA Received07/03/2018
08/10/2018
08/22/2018
Date Device Manufactured12/16/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-0591-2009
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-